Literature DB >> 25003607

Engrailed-2 protein as a potential urinary prostate cancer biomarker: a comparison study before and after digital rectal examination.

Michał Piotr Marszałł1, Wiktor Sroka, Marek Adamowski, Piotr Słupski, Piotr Jarzemski, Joanna Siódmiak, Grażyna Odrowąż-Sypniewska.   

Abstract

This study was designed to compare and evaluate the presence of engrailed-2 (EN2) protein in urine collected before and after prostate massage as a diagnostic marker for prostate cancer (PCa). We analysed and compared 76 urine samples (38 before and 38 after prostate massage) from the benign group (BPH) and 66 urine samples (33 before and 33 after prostate massage) from patients with PCa confirmed by prostate biopsy. EN2 levels from the PCa and men with BPH (age range 50-82) were related to the tumour stage, Gleason score and prostate-specific antigen. EN2 levels were determined by enzyme-linked immunosorbent assay in urine. The median EN2 levels in urine after prostate massage were significantly different from those determined in urine before prostate massage (1.25 ng/ml in the PCa group and 0.34 ng/ml in the BPH). The mean EN2 levels in PCa patients were 3.76-fold higher than those in non-PCa patients after prostate massage. The distinct influence of prostate massage on EN2 levels was found to be related to the Gleason score and tumour stage. EN2 may be considered a marker of PCa with certain limitations, such as those related to tumour staging. The specificity and sensitivity of the protocol are highly dependent on prostate massage.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25003607     DOI: 10.1097/CEJ.0000000000000046

Source DB:  PubMed          Journal:  Eur J Cancer Prev        ISSN: 0959-8278            Impact factor:   2.497


  10 in total

1.  Deficiency of the chromatin regulator BRPF1 causes abnormal brain development.

Authors:  Linya You; Jinfeng Zou; Hong Zhao; Nicholas R Bertos; Morag Park; Edwin Wang; Xiang-Jiao Yang
Journal:  J Biol Chem       Date:  2015-01-07       Impact factor: 5.157

2.  Biological function and mechanism of miR-33a in prostate cancer survival and metastasis: via downregulating Engrailed-2.

Authors:  Q Li; S Lu; X Li; G Hou; L Yan; W Zhang; B Qiao
Journal:  Clin Transl Oncol       Date:  2016-12-05       Impact factor: 3.405

Review 3.  Transcription Factors: Potential Cell Death Markers in Parkinson's Disease.

Authors:  Ronglin Wang; Shaosong Yang; Tiejian Nie; Gang Zhu; Dayun Feng; Qian Yang
Journal:  Neurosci Bull       Date:  2017-08-08       Impact factor: 5.203

4.  Engrailed-2 promoter hyper-methylation is associated with its downregulation in clear cell renal cell carcinoma.

Authors:  Cai-Yong Lai; Gan-Shen Yu; Yin Xu; Xun Wu; Bao-Li Heng; Yi-Jun Xue; Ze-Xuan Su
Journal:  Oncol Lett       Date:  2017-09-19       Impact factor: 2.967

5.  The biological functions and mechanism of miR‑212 in prostate cancer proliferation, migration and invasion via targeting Engrailed-2.

Authors:  Yi Zhou; Zhigang Ji; Weigang Yan; Zhien Zhou; Hanzhong Li
Journal:  Oncol Rep       Date:  2017-07-12       Impact factor: 3.906

6.  Membrane insertion and secretion of the Engrailed-2 (EN2) transcription factor by prostate cancer cells may induce antiviral activity in the stroma.

Authors:  Natasha Punia; Monika Primon; Guy R Simpson; Hardev S Pandha; Richard Morgan
Journal:  Sci Rep       Date:  2019-03-26       Impact factor: 4.379

7.  Engrailed 1 overexpression as a potential prognostic marker in quintuple-negative breast cancer.

Authors:  Yu Jin Kim; Minjung Sung; Ensel Oh; Michael Van Vrancken; Ji-Young Song; Kyungsoo Jung; Yoon-La Choi
Journal:  Cancer Biol Ther       Date:  2018-02-13       Impact factor: 4.742

8.  Oncogenic Role of Secreted Engrailed Homeobox 2 (EN2) in Prostate Cancer.

Authors:  Enrique Gómez-Gómez; Juan M. Jiménez-Vacas; Sergio Pedraza-Arévalo; Fernando López-López; Vicente Herrero-Aguayo; Daniel Hormaechea-Agulla; José Valero-Rosa; Alejandro Ibáñez-Costa; Antonio J. León-González; Rafael Sánchez-Sánchez; Teresa González-Serrano; Maria J. Requena-Tapia; Justo P. Castaño; Julia Carrasco-Valiente; Manuel D. Gahete; Raúl M. Luque
Journal:  J Clin Med       Date:  2019-09-06       Impact factor: 4.241

9.  Engrailed 2 (EN2) acts as a glioma suppressor by inhibiting tumor proliferation/invasion and enhancing sensitivity to temozolomide.

Authors:  Tengfei Li; Wanchun Yang; Mao Li; Shuxin Zhang; Xingwang Zhou; Mingrong Zuo; Qiuyun Yuan; Mina Chen; Yanhui Liu
Journal:  Cancer Cell Int       Date:  2020-03-02       Impact factor: 5.722

Review 10.  Graphene-based biosensors for the detection of prostate cancer protein biomarkers: a review.

Authors:  Li Xu; Yanli Wen; Santosh Pandit; Venkata R S S Mokkapati; Ivan Mijakovic; Yan Li; Min Ding; Shuzhen Ren; Wen Li; Gang Liu
Journal:  BMC Chem       Date:  2019-09-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.